Related Experiment Videos
Beta 2 adrenergic receptor 5' haplotypes influence promoter activity
Sharon E Johnatty1, Maha Abdellatif, Lawrence Shimmin
1Human Genetics Center, University of Texas School of Public Health, 1200 Herman Pressley RAS E477, Houston, TX 77030, U.S.A.
British Journal of Pharmacology
|December 6, 2002
Summary
Genetic variations in the beta(2) adrenergic receptor gene promoter interact to significantly alter gene expression. These complex genetic effects, not individual changes, impact receptor levels and may influence disease risk.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- The human beta(2) adrenergic receptor gene (ADRB2) is crucial for various physiological processes.
- Transcriptional regulation of ADRB2 is primarily controlled by a promoter region.
- Four common polymorphisms (-468 C-->G, -367 T-->C, -47 T-->C, -20 T-->C) exist within this regulatory region.
Purpose of the Study:
- To investigate the individual and combined (haplotype) effects of four ADRB2 promoter polymorphisms on gene expression.
- To determine if interactions between polymorphisms significantly influence ADRB2 transcriptional activity.
Main Methods:
- Generated 16 luciferase reporter constructs with different combinations of ADRB2 promoter polymorphisms.
- Transfected constructs into HEK293 cells and measured luciferase activity.
- Analyzed individual and haplotype effects on promoter-driven gene expression.
Main Results:
- Two specific haplotypes (GCCT and CTCT) demonstrated a significant threefold decrease in ADRB2 promoter activity compared to the reference (CTTT).
- The observed haplotype effects were greater than the sum of individual polymorphism effects, indicating interaction.
- Individual polymorphism effects did not fully explain the observed changes in gene expression.
Conclusions:
- Promoter polymorphisms in the ADRB2 gene interact synergistically to modulate receptor expression levels.
- These complex genetic interactions, rather than single nucleotide changes, are critical for regulating ADRB2 transcription.
- Further research is warranted to explore the association of these interacting polymorphisms with disease phenotypes.